"Naproxen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.
| Descriptor ID |
D009288
|
| MeSH Number(s) |
D02.455.426.559.847.638.472.500 D04.615.638.472.450
|
| Concept/Terms |
Naproxen Sodium- Naproxen Sodium
- Sodium, Naproxen
- Sodium Naproxenate
- Naproxenate, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Naproxen".
Below are MeSH descriptors whose meaning is more specific than "Naproxen".
This graph shows the total number of publications written about "Naproxen" by people in this website by year, and whether "Naproxen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naproxen" by people in Profiles.
-
Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015 Jan 06; 162(1):46-54.
-
Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG. Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example. Alzheimers Dement. 2014 Mar; 10(2):152-61.
-
McCormick DL, Phillips JM, Horn TL, Johnson WD, Steele VE, Lubet RA. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors. Cancer Prev Res (Phila). 2010 Jan; 3(1):73-81.
-
Goldberg SA, O'Connor SC, Sprinz PG. Prostaglandin inhibitors in the treatment of single-system Langerhans cell histiocytosis: pharmacologic rationale and report of two cases. J Pediatr Hematol Oncol. 2008 Oct; 30(10):778-80.
-
Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84.
-
Yood RA. NSAID gastropathy. Arch Intern Med. 1997 Feb 10; 157(3):364.
-
Walker AM, Bortnichak EA, Lanza L, Yood RA. The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs. Arch Fam Med. 1995 Jan; 4(1):24-9.
-
Aghababian RV, Volturo GA, Heifetz IN. Comparison of diflunisal and naproxen in the management of acute low back strain. Clin Ther. 1986; 9 Suppl C:47-51.
-
Klempner MS, Dinarello CA, Gallin JI. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest. 1978 May; 61(5):1330-6.